4basebio at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

4basebio brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on synthetic enzymatic DNA as a replacement for plasmid DNA. It covers a single-stranded DNA platform for non-viral CRISPR editing and rAAV made without bacterial backbone sequences to improve safety.

OrganizationESGCT 2026 Attendance
4basebio
Cambridge, UK
4basebio.com
CDMOs & CROs
Makes synthetic DNA by a cell-free enzymatic process, an alternative to plasmid DNA for gene therapies and vaccines.
Poster
Wed Oct 28
1:30pm–3:30pm
An enzymatic ssDNA platform addresses manufacturing and performance bottlenecks in non-viral CRISPR gene editing
Gene Editing
Poster
Wed Oct 28
1:30pm–3:30pm
Improving rAAV safety profiles by using synthetic DNA free of bacterial backbone sequences
Manufacturing

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from 4basebio

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction